ChronoScale Corporation (LON:0IFR)

Market Cap	1.52B +13,698.3%
Revenue (ttm)	n/a -34.1%
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41
Average Volume	2,380
Open	13.60
Previous Close	15.50
Day's Range	13.27 - 14.12
52-Week Range	3.69 - 16.73
Beta	1.88
RSI	71.59
Earnings Date	Jul 27, 2026

About ChronoScale

ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Country: United States
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IFR

Financial Performance

In 2025, Ekso Bionics Holdings's revenue was $12.80 million, a decrease of -28.60% compared to the previous year's $17.93 million. Losses were -$11.92 million, 5.22% more than in 2024.

Financial numbers in USD